Press Releases Isracann Biosciences Inc.

Equities

IPOT

CA46501D1087

Market Closed - Canadian Securities Exchange Other stock markets 08:11:13 05/04/2023 pm IST			5-day change	1st Jan Change
0.015 ^CAD	-.--%		-.--%	-.--%

26/04	Isracann Biosciences Inc. Announces Resignation of Directors	CI
23/01	Isracann Biosciences Inc. Announces Management Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CSE Bulletin: Suspensions (IPOT, TCAN)	06/23/06	NE
IIROC Trading Halt - IPOT	06/23/06	AQ
Isracann Biosciences Provides Bi-Weekly Default Status Report	13/22/13	GL
Isracann Biosciences Announces Delay in Filing Annual Financial Statements	30/22/30	GL
Isracann Bioscience Facilitated Genetics Arrive in Israel	28/22/28	GL
Isracann Bioscience Facilitated Genetics Arrive in Israel	28/22/28	AQ
Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel	14/22/14	GL
Isracann Biosciences Inc. - Praesidio signs distribution agreement with Pure Integrative Pharmacy	02/22/02	AQ
Praesidio signs distribution agreement with Pure Integrative Pharmacy	01/22/01	GL
Praesidio signs distribution agreement with Pure Integrative Pharmacy	01/22/01	AQ
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board	23/22/23	GL
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board	23/22/23	AQ
Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement	03/22/03	GL
Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement	03/22/03	AQ
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada	19/22/19	GL
Isracann Biosciences Renews Leadership to Meet Changing Demands	15/22/15	AQ
Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers	13/22/13	GL
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer	28/22/28	GL
UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer	25/22/25	GL
Isracann Signs LOI to Acquire Natural Health Medicine Developer	23/22/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Isracann Biosciences Inc.

Equities

IPOT

CA46501D1087

Press Releases

Filters